Stop TB Partnership has invited tenders for the production of bedaquiline, the first new therapy to be made available for tuberculosis (TB) in 40 years. The drugs will be supplied via generic production to lower and middle income countries, including those where patents are still in effect. The move is designed to reduce the price and improve access to the key TB medication.